Literature DB >> 15494830

Unusual location of eosinophilic granuloma.

Ammar S Haouimi1, Zakaria M Al-Hawsawi, Ahmed N Jameel.   

Abstract

Eosinophilic granuloma EG is a benign self-limiting disease, which belongs to the spectrum of Langerhans' cell histiocytosis LCH. The etiology of LCH remains unknown, although the evidence indicates that it is a clonal proliferative disorder of Langerhans cells, it has also been characterized as reactive disorder, neoplastic process and a berrant immune response. Eosinophilic granuloma is characterized by single or multiple skeletal lesions occurring predominately in children, adolescents and young adults, it accounts for 70% of LCH. It is more common in males, and the common sites are the skull, mandible, ribs, spines and long bones particularly the femur and the humerus. The estimated incidence of EG is 3-4 per million of the population. Vertebral bone involvement is rarely seen and usually affects the vertebral body. We are reporting an unusual case of EG in a female child presented with a solitary lesion at posterior element of lumbar vertebra.

Entities:  

Mesh:

Year:  2004        PMID: 15494830

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  3 in total

1.  A case of eosinophilic granuloma of the skull in an adult man: a case report.

Authors:  Panagiotis V Kitsoulis; Georgios Paraskevas; Aristidis Vrettakos; Aikaterini Marini
Journal:  Cases J       Date:  2009-12-04

2.  Eosinophilic granuloma of skull bone.

Authors:  Rashmi Kaul; Neelam Gupta; Sourav Gupta; Manish Gupta
Journal:  J Cytol       Date:  2009-10       Impact factor: 1.000

3.  Localized Chronic Form of Langerhans Cell Histiocytosis in the Femur of a 16-Year-Old Male Successfully Treated with Radiofrequency Ablation.

Authors:  Kyriakos Papavasiliou; Antonia Bintoudi; Apostolos Vlahodimos; Eleftherios Tsiridis; Prodromos Hytiroglou; Ioannis Tsitouridis; Fares Sayegh
Journal:  Case Rep Oncol Med       Date:  2020-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.